Noida, UP -- (SBWIRE) -- 07/29/2015 -- According to a new research report by RNCOS entitled, "Global Erythropoietin Market Outlook 2020", the US dominates the erythropoietin market in the world whereas the emerging countries of Asia Pacific region are moving towards manufacturing of EPO biosimilars hindering the global erythropoietin market.

Epoetin alfa, which includes Johnson & Johnson's Procrit and Amgen's Epogen, is considered to be the most demanded erythropoietin drug in the world; however Darbepoetin alfa drug is the emerging erythropoietin drug in the global erythropoietin market but is expected to witness negative growth in future. The market is anticipated to grow at -0.5% CAGR to become US$ 6.3 Billion by 2020. Johnson & Johnson, Roche Inc. and Amgen are major erythropoietin companies.

Research Analysis and Highlights

The report is spread in over 40 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Global Erythropoietin Industry. The study presents transparent picture major erythropoietin drugs such as Epogen, Ararnesp, Procrit/Eprex, Mircera, NeoRecormon and others including the factors affecting their growth. The research further covers global erythropoietin industry, detailed analysis of geographical segments as well as applications of erythropoietin.

The report also covers detailed information about active market players in the Global Erythropoietin Industry, including small and large players to enable the clients understand the market structure and its growth during the forecasted period. In brief, the report, "Global Erythropoietin Market Outlook 2020", covers all the necessary aspects of the global erythropoietin industry, providing an in-depth research and prudent analysis of the key segments.

Some of the key findings of the report are:

- Major erythropoietin applications such as cancer treatments and renal anemia treatment and their current outlook
- Major erythropoietin drugs such as Epogen, Ararnesp, Procrit/Eprex, Mircera, NeoRecormon and their current outlook
- Geographical Segmentation- US and Rest of the World
- Leading Players and their share in global erythropoietin industry

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM771.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.